Major Cardiovascular Consequences of Familial Hypercholesterolemia in Poland from the Economic Perspective
Journal Title: JOURNAL OF HEALTH POLICY & OUTCOMES RESEARCH - Year 2017, Vol 2, Issue 2
Abstract
Background. Familial hypercholesterolemia (FH) is a genetic disease characterised by high LDL-C level with other lipid fractions levels typically correct. The disease involves the accelerated development of arteriosclerosis and vascular complications, mainly coronary disease. Patients with FH have an increased risk of the acute coronary syndrome (ACS), ischemic stroke (IS) and peripheral artery disease (PAD). Aims. This publication aims to discuss epidemiology and costs associated with three major vascular complications of FH: ACS (including myocardial infarction, MI), IS and PAD. In case of lack of specific data for FH subpopulation, more general data will be discussed. Results. Meta-analysis of six Polish population studies indicated that heterozygous FH morbidity in Poland is approximately 404/100,000 people what corresponds with approximately 150,000 patients. Each year 123 thousand ACS are reported in Poland of what approximately 62% is a MI. In European population FH is diagnosed in approximately 8.3% patients with ACS (in Polish subpopulation – approximately 11.4%). Total hospitalization costs due to ACS among patients with FH in 2016 equaled PLN 108-148 million, of what hospitalization cost due to MI was approximately PLN 67-91 million. Indirect medical costs during first 36 months after MI in patients with FH may be estimated for PLN 128-175 million and indirect costs of MI in patients with FH for PLN 257-684 million. Conclusions. Early screening for familial hypercholesterolemia and efficient hypolipemic treatment are a chance for significant reduction of incidence of discussed vascular complications and their costs within the healthcare system. We were not able to identify any specific cost data for FH subpopulations of IS and PAD patients.
Authors and Affiliations
Ewa Kamińska, Iwona Dobrowolska, Alicja Wójcik, Katarzyna Młyńczak, Joanna Lis, Marta Dąbrowska, Beata Wójtowicz, Anna Smolarska, Maciej Niewada, Dominik Golicki
Keywords
Related Articles
- EP ID EP326183
- DOI 10.7365/JHPOR.2017.2.2
- Views 74
- Downloads 0
Treatment options in chronic lymphocytic leukemia (CLL) – a Polish perspective
Chronic lymphocytic leukemia (CLL) is the most frequent type of leukemia among the elderly people in Western societies. CLL is genetically and molecularly heterogeneous disease that translates into clinical outcomes. Cur...
Cost-effectiveness study of diagnosis strategies of acute viral infections in Ukraine
Background: Efficient and accurate laboratory diagnosis of viral pathogens is of primary importance for clinical care in terms of health care system reforms. The methodological approach of cost-effectiveness analysis of...
Approach to uncertainty in health technology assessment in a Central and Eastern European country: appraisal of cancer drugs by a Polish HTA agency in presence of high crossover rates in clinical trials
Background: Health technology assessment (HTA) plays an important role in reimbursement decision making in Poland and its principles are similar to those used in other countries. However, specific inter-country differenc...
Multiple Criteria Decision Analysis (MCDA) for Health Care Decision Making – overview of guidelines
Multidimensional context of decision making in health care implies the need for structured approach which can be supported by Multiple Criteria Decision Analysis (MCDA). Despite the fact that MCDA is more widely discuss...
The adaptation of new methodology of quality of life assessment in patients with thrombocytopenia in Ukraine as a result of Polish-Ukrainian collaboration
Objective. Our aim was linguistic adaptation the Thrombocytopenia Symptoms and their Impact on patients Daily Activities Assessment Vignette (TSIDAV) into Ukrainian. Methods: In the translation process were involved two...